Novartis (Mexico) Technical Analysis
| NVSN Stock | MXN 2,004 134.33 6.28% |
As of the 19th of December, Novartis secures the Standard Deviation of 0.9382, risk adjusted performance of (0.07), and Mean Deviation of 0.3134. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG, as well as the relationship between them.
Novartis Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Novartis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NovartisNovartis |
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Novartis AG Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Novartis AG volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Novartis AG Trend Analysis
Use this graph to draw trend lines for Novartis AG. You can use it to identify possible trend reversals for Novartis as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Novartis price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Novartis Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Novartis AG applied against its price change over selected period. The best fit line has a slop of 1.15 , which may suggest that Novartis AG market price will keep on failing further. It has 122 observation points and a regression sum of squares at 50224.21, which is the sum of squared deviations for the predicted Novartis price change compared to its average price change.About Novartis Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novartis AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novartis AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novartis AG price pattern first instead of the macroeconomic environment surrounding Novartis AG. By analyzing Novartis's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novartis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novartis specific price patterns or momentum indicators. Please read more on our technical analysis page.
Novartis December 19, 2024 Technical Indicators
Most technical analysis of Novartis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novartis from various momentum indicators to cycle indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 0.3134 | |||
| Coefficient Of Variation | (1,096) | |||
| Standard Deviation | 0.9382 | |||
| Variance | 0.8802 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.12) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 4.88 | |||
| Value At Risk | (1.09) | |||
| Skewness | (3.97) | |||
| Kurtosis | 31.68 |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.